After gains of 2.5% this afternoon, Elanco Animal Health shares are now trading at $13.85. Read below for the essential facts about this stock:
-
Elanco Animal Health has logged a -24.8% 52 week change, compared to 11.2% for the S&P 500
-
ELAN has an average analyst rating of buy and is -6.82% away from its mean target price of $14.86 per share
-
Its trailing earnings per share (EPS) is $0.75, which brings its trailing Price to Earnings (P/E) ratio to 18.5. The Health Care sector's average P/E ratio is 22.94
-
The company's forward earnings per share (EPS) is $0.94 and its forward P/E ratio is 14.7
-
The company has a Price to Book (P/B) ratio of 1.08 in contrast to the Health Care sector's average P/B ratio is 3.19
-
The current ratio is currently 2.4, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
ELAN has reported YOY quarterly earnings growth of 116.7% and gross profit margins of 0.5%
-
The company's free cash flow for the last fiscal year was $394.0 Million and the average free cash flow growth rate is 36.2%
-
Elanco Animal Health's revenues have an average growth rate of 7.0% with operating expenses growing at 8.4%. The company's current operating margins stand at 11.0%